Immix Biopharma (IMMX) Tax Rate (2021 - 2025)
Quarterly results put Tax Rate at 0.11% for Q4 2025, down 18.0% from a year ago — trailing twelve months through Dec 2025 was 0.13% (up 253.0% YoY), and the annual figure for FY2025 was 0.13%, up 253.0%.
Immix Biopharma has reported Tax Rate over the past 5 years, most recently at 0.11% for Q4 2025.
- Tax Rate reached 0.11% in Q4 2025 per IMMX's latest filing, down from 0.1% in the prior quarter.
- Across five years, Tax Rate topped out at 0.07% in Q4 2024 and bottomed at 0.78% in Q2 2021.
- Median Tax Rate over the past 5 years was 0.16% (2021), compared with a mean of 0.17%.
- The largest annual shift saw Tax Rate surged 67bps in 2022 before it dropped -18bps in 2025.
- Over 5 years, Tax Rate stood at 0.01% in 2021, then plummeted by -2035bps to 0.14% in 2022, then fell by -13bps to 0.16% in 2023, then soared by 145bps to 0.07% in 2024, then tumbled by -250bps to 0.11% in 2025.
- Business Quant data shows Tax Rate for IMMX at 0.11% in Q4 2025, 0.1% in Q3 2025, and 0.13% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 56.85 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 5.61 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 17.68 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 12.51 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -6.79 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 7.07 |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.11 |
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | -0.10 |
| Sep 30, 2025 | -0.10 |
| Jun 30, 2025 | -0.13 |
| Jun 30, 2025 | -0.13 |
| Mar 31, 2025 | -0.22 |
| Mar 31, 2025 | -0.22 |
| Dec 31, 2024 | 0.07 |
| Dec 31, 2024 | 0.07 |
| Sep 30, 2024 | -0.16 |
| Sep 30, 2024 | -0.16 |
| Jun 30, 2024 | -0.23 |
| Jun 30, 2024 | -0.23 |
| Mar 31, 2024 | -0.17 |
| Mar 31, 2024 | -0.17 |
| Dec 31, 2023 | -0.16 |
| Dec 31, 2023 | -0.16 |
| Sep 30, 2023 | -0.16 |
| Sep 30, 2023 | -0.16 |
| Jun 30, 2023 | -0.18 |
| Jun 30, 2023 | -0.18 |
| Mar 31, 2023 | -0.21 |
| Mar 31, 2023 | -0.21 |
| Dec 31, 2022 | -0.14 |
| Dec 31, 2022 | -0.14 |
| Sep 30, 2022 | -0.11 |
| Sep 30, 2022 | -0.11 |
| Jun 30, 2022 | -0.11 |
| Jun 30, 2022 | -0.11 |
| Mar 31, 2022 | -0.12 |
| Mar 31, 2022 | -0.12 |
| Dec 31, 2021 | -0.01 |
| Dec 31, 2021 | -0.01 |
| Sep 30, 2021 | -0.33 |
| Sep 30, 2021 | -0.33 |
| Jun 30, 2021 | -0.78 |
| Jun 30, 2021 | -0.78 |
| Mar 31, 2021 | -0.16 |
| Mar 31, 2021 | -0.16 |